295 results on '"Pescovitz, M. D."'
Search Results
2. Polyomavirus BK Replication in De Novo Kidney Transplant Patients Receiving Tacrolimus or Cyclosporine: A Prospective, Randomized, Multicenter Study
3. Analysis and clinical correlation of genetic variation in cytomegalovirus
4. Effects of the Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease in Organ Transplant Recipients
5. Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients
6. Giving Birth to an Operation: Laparoscopic Live Donor Nephrectomy with Vaginal Extraction. Is This Misconceived?
7. Valganciclovir: Recent Progress
8. Improved cyclosporine pharmacokinetics in maintenance renal transplant recipients converted to cyclosporine for microemulsion
9. Supplement to: Rituximab, B-lymphocyte depletion, and preservation of beta-cell function
10. A Randomized, Double-Blind, Pharmacokinetic Study of Oral Maribavir with Tacrolimus in Stable Renal Transplant Recipients
11. Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients
12. An Assessment of Herpesvirus Co-infections in Patients with CMV Disease: Correlation with Clinical and Virologic Outcomes
13. Phase 1 Dose-Escalation Study of CP-690 550 in Stable Renal Allograft Recipients: Preliminary Findings of Safety, Tolerability, Effects on Lymphocyte Subsets and Pharmacokinetics
14. Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients
15. Once-Daily Tacrolimus Extended-Release Formulation: 1-Year Post-Conversion in Stable Pediatric Liver Transplant Recipients
16. Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus
17. Elimination of false-positive Histoplasma antigenemia caused by human anti-rabbit antibodies in the second-generation Histoplasma antigen assay
18. C4d Deposition and Clearance in Cardiac Transplants Correlates With Alloantibody Levels and Rejection in Rats
19. Rituximab, an Anti-CD20 Monoclonal Antibody: History and Mechanism of Action
20. Ultrasound-guided pediatric liver transplant biopsy using a pring-propelled cutting needle (biopsy gun)
21. False-positive Histoplasma antigenemia caused by antithymocyte globulin antibodies
22. Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics
23. The Pig as a Model to Assess the Effect of Class II MHC Antigen Matching on Renal Allograft Survival
24. Analyses of monoclonal antibodies reacting with porcine wCD6 Results from the Second International Swine CD Workshop
25. RISK FACTORS OF POLYOMAVIRUS BKV HIGH-LEVEL VIRURIA AND VIREMIA IN DE NOVO RENAL TRANSPLANTATION: A MULTIVARIATE ANALYSIS FROM THE DIRECT STUDY COMPARING CYCLOSPORINE AND TACROLIMUS
26. DONOR SPECIFIC ANTIBODY CHANGES AFTER NEPHRECTOMY
27. Overview of the Third International Workshop on Swine Leukocyte Differentiation Antigens
28. ORAL VALGANCICLOVIR AND INTRAVENOUS GANCICLOVIR RESULTS IN COMPARABLE LONG-TERM OUTCOMES IN TRANSPLANT RECIPIENTS WITH CMV DISEASE: THE VICTOR STUDY
29. THE EFFECT OF GASTRIC PH MODULATORS ON THE PHARMACOKINETICS OF MYCOPHENOLATE MOFETIL (MMF) IN DE NOVO RENAL TRANSPLANT PATIENTS.
30. IMMUNOSUPPRESSIVE PROPERTIES OF MYCOPHENOLATE MOFETIL AND VALGANCICLOVIR USED IN COMBINATION IN RENAL TRANSPLANT PATIENTS
31. A NEW CROSSMATCH TECHNIQUE ELIMINATES INTERFERENCE BY HUMANIZED AND CHIMERIC DRUGS
32. Impact of Diabetic Status on Mycophenolic Acid (MPA) Exposure Using Mycophenolate Mofetil (MMF) in De Novo Renal Transplant Patients.
33. Analyses of monoclonal antibodies reacting with porcine CD5:results from the 2. International Swine CD Workshop
34. Report on the analyses of mAb reactive with porcine CD8 for the 2. International Swine CD Workshop
35. Analyses of monoclonal antibodies reacting with porcine wCD6:results from the 2. International Swine CD Workshop
36. Summary of the first round analyses of the 2. International Swine CD Workshop
37. Summary of workshop findings for antibodies reacting with porcine T-cells and activation antigens:results from the 2. International Swine CD Workshop
38. Overview of the Second International Workshop to define swine cluster of differentiation (CD) antigens
39. Report on the analyses of mAb reactive with porcine CD8 for the Second International Swine CD Workshop
40. Analyses of monoclonal antibodies reacting with porcine CD5 Results from the Second International Swine CD Workshop
41. Summary of workshop findings for antibodies reacting with porcine T- cells and activation antigens Results from the Second International Swine CD Workshop
42. Overview of the Second International Workshop to define Swine Cluster of Differentiation (CD) antigens
43. The Second International Swine CD Workshop
44. Analysis of monoclonal antibodies reactive with the porcine CD2 antigen
45. Analyses of monoclonal antibodies reactive with porcine CD6
46. Analysis of mAb reactive with the porcine SWC1
47. Analyses of mAb reactive with porcine CD8
48. Summary of workshop findings for porcine T-lymphocyte antigens
49. Overview of the first international workshop to define swine leukocyte cluster of differentiation (CD) antigens
50. SIROLIMUS DOES NOT PREVENT SEROCONVERSION IN CMV SERONEGATIVE RECIPIENTS OF CMV SEROPOSITIVE KIDNEYS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.